BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Human epidermal growth factor receptor 2
1
Emergence of human epidermal growth factor receptor 2 as key biomarker and therapeutic target in advanced urothelial carcinoma
7/24/2026 6:11:15 AM | Browse: 57 | Download: 70
2
Advancing precision medicine in human epidermal growth factor receptor 2 negative gastric cancer: Insights from a novel nomogram for immunochemotherapy prognosis
2/3/2026 6:28:03 AM | Browse: 165 | Download: 343
3
Colorectal cancer metastasis to the brain: A scoping review of incidence, treatment, and outcomes
12/22/2025 7:43:01 AM | Browse: 270 | Download: 409
4
Perioperative immunotherapy combined with standard therapy for human epidermal growth factor receptor 2-positive locally advanced gastric cancer: A case report
11/21/2025 7:06:13 AM | Browse: 295 | Download: 619
5
Human epidermal growth factor receptor 2 overexpression is associated with high-grade tumors in upper tract urothelial carcinoma
10/24/2025 6:10:15 AM | Browse: 96 | Download: 398
6
Deciphering prognostic markers in gastric signet ring cell carcinoma: Human epidermal growth factor receptor 2 and other key factors
8/20/2025 8:41:26 AM | Browse: 390 | Download: 1028
7
Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report
3/25/2025 4:19:10 PM | Browse: 207 | Download: 945
8
Efficacy of disitamab vedotin-containing therapy in metastatic colorectal cancer: A case report
1/21/2025 9:22:13 AM | Browse: 300 | Download: 953
9
BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer
10/25/2024 10:27:30 AM | Browse: 176 | Download: 1067
10
Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer
6/15/2024 2:49:03 AM | Browse: 290 | Download: 1084
11
Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer
5/21/2024 7:25:52 AM | Browse: 152 | Download: 981
12
PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report
3/6/2024 6:10:52 AM | Browse: 446 | Download: 1139
13
Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
10/22/2021 9:56:10 AM | Browse: 797 | Download: 1575
14
HER2-positive adenocarcinoma arising from heterotopic pancreas tissue in the duodenum: A case report
7/26/2021 11:20:59 AM | Browse: 985 | Download: 2310
15
Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report
9/10/2020 5:57:28 AM | Browse: 1131 | Download: 2522
16
HER2 heterogeneity is a poor prognosticator for HER2 positive gastric cancer
8/6/2019 11:50:46 AM | Browse: 1564 | Download: 2441
17
Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
4/15/2019 10:50:47 AM | Browse: 1422 | Download: 3095
18
Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation times
2/26/2019 9:05:11 AM | Browse: 1206 | Download: 2597
19
Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
9/28/2018 10:31:14 AM | Browse: 1233 | Download: 2391
20
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
7/15/2018 9:50:44 AM | Browse: 1474 | Download: 1943
21
Targeted therapies in breast cancer: New challenges to fight against resistance
4/7/2017 8:24:12 AM | Browse: 1487 | Download: 2641
22
Recent developments and innovations in gastric cancer
4/29/2016 4:50:00 PM | Browse: 2040 | Download: 2993
23
Companion diagnostics for the targeted therapy of gastric cancer
12/10/2015 10:17:00 AM | Browse: 1207 | Download: 2122
24
Human epidermal growth factor receptor 2 amplification and protein expression in mixed gastric carcinoma
4/30/2015 2:11:00 PM | Browse: 1287 | Download: 2540
25
Recent advances in the HER2 targeted therapy of gastric cancer
1/14/2015 10:56:00 AM | Browse: 1628 | Download: 1895
26
Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?
12/12/2014 11:15:00 AM | Browse: 1451 | Download: 1949
27
Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer
9/16/2014 1:19:00 PM | Browse: 1442 | Download: 1218
28
HER2 therapies and gastric cancer: A step forward
9/12/2014 8:40:00 PM | Browse: 1363 | Download: 1367
29
Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies
9/12/2014 8:40:00 PM | Browse: 1403 | Download: 1405
30
Death decoy receptor overexpression and increased malignancy risk in colorectal cancer
8/29/2014 11:31:00 AM | Browse: 1166 | Download: 1629
31
Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects
8/28/2014 5:50:00 PM | Browse: 1644 | Download: 1609